Experts analysed alcohol-related hospital admissions for 40,703 people who had started either semaglutide, which includes the brand Wegovy, or tirzepatide, also known as Mounjaro, between January 2018 and December 2024
Summary of Benefits Fast eligibility quiz and onboarding No insurance required Transparent, flat-rate pricing Nationwide medication delivery Licensed clinical oversight and unlimited messaging Access to both compounded and name-brand GLP-1 medications These features make FuturHealth one of the most accessible and consumer-friendly options in the telehealth weight loss space
Koncz, D., Tth, B., Bahar, M
Most users have found their optimal dose, and the medication is working at full capacity
Compounded meds should only be considered when there is a national drug shortage, and no approved product is available
Diet and lifestyle modifications during treatment can dramatically influence outcomes with either Mounjaro or retatrutide